ARCHIVES

Adriamycin Update Discussed At Seminar

This article is from The Cancer Letter archive.

Vol. 01 No. 02 | January 10, 1975

Download PDF Visit The Full Archive

Related Articles

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002